This last week of 2022, Infection Control Today® reviews the most popular articles. Here are the 7th, 6th, and 5th.
Infection Control Today® (ICT®) strives all year to give you the best, most helpful information to do your job. Starting with the tenth most popular article, we will countdown the Top 10 most popular articles ICT® posted in 2022.
Here are the 7th, 6th, and 5th most popular articles:
7th Most Popular Article: COVID-19 Brain Changes: New Evidence Details Long-Term Effects of Infection
A new study supports the conclusion that the “brain fog” reported by many who have recovered from mild COVID-19 infection is real and has an anatomical basis.
6th Most Popular Article: The Role of Health Care Laundry in Infection Prevention
Environmental sources of pathogen organisms can sometimes be difficult to narrow down in a health care facility. One possible source of transmission is the laundry used, and not maintaining strict cleanliness attention can put both patients and workers at risk.
5th Most Popular Article: Monkeypox: CDC Raises Travel Alert, But How Much Threat Is it Really?
With more confirmed cases in the United States, and the CDC raising the travel alert to Level 2, should individuals be concerned? ICT investigates.
Comprehensive Strategies in Wound Care: Insights From Madhavi Ponnapalli, MD
November 22nd 2024Madhavi Ponnapalli, MD, discusses effective wound care strategies, including debridement techniques, offloading modalities, appropriate dressing selection, compression therapy, and nutritional needs for optimal healing outcomes.
The Leapfrog Group and the Positive Effect on Hospital Hand Hygiene
November 21st 2024The Leapfrog Group enhances hospital safety by publicizing hand hygiene performance, improving patient safety outcomes, and significantly reducing health care-associated infections through transparent standards and monitoring initiatives.
Managing Multimorbidity and Polypharmacy in HIV: Insights From Michelle S. Cespedes, MD, MS
November 20th 2024Michelle S. Cespedes, MD, MS, discusses the challenges of managing multimorbidity and polypharmacy in HIV treatment, emphasizing patient education, evolving guidelines, and real-world insights from the REPRIEVE study.
Longhorn Vaccines and Diagnostics to Showcase Breakthrough Vaccine Data at IDWeek 2024
November 19th 2024Longhorn Vaccines and Diagnostics revealed promising data on universal influenza vaccine LHNVD-110 and AMR sepsis vaccine LHNVD-303 at IDWeek 2024, addressing critical global health challenges.